No relationship between the amount of DNA damage and the level of hMLH1 and RASSF1A gene expression in bladder cancer cells treated with cisplatin and gemcitabine.

Autor: Camargo EA; Department of Pathology, Sao Paulo State University, Botucatu Medical School, Botucatu, Brazil E-mail : acelainebio@yahoo.com.br., da Silva GN, Gobette CP, Marcondes JP, Salvadori DM

Publikováno v: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2013; Vol. 14 (10), pp. 5941-8.